Ex vivo tumor analysis on day 33 indicated a low but significant intratumoral CD3ε+ EGFRt+ CAR-T cell population in EC17-treated animals which amounted to ~1% total viable digested tumor-derived cells (Figure 9C, right bar graph). This evidence concerns the gene CD3E and neoplasm.